Clinical study about the safety of Suvorexant for severe sleep apnea syndrome
Phase 4
- Conditions
- Sleep Apnea Syndrome
- Registration Number
- JPRN-jRCTs041180086
- Lead Sponsor
- Imaizumi Kazuyoshi
- Brief Summary
There was no significant difference in the AHI of patients with severe sleep apnea before and after taking Suvorexant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
The patient who received enough explanation about this study, and provides agreement in the document.
Exclusion Criteria
The patient 19 years or younger at the time of the agreement acquisition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Apnea hypopnea index on PSG
- Secondary Outcome Measures
Name Time Method Epworth sleepiness scale